Drug
CN128 clinical trials
Also written CN128.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
4 studies that test it; most in 2018 (2)
| Year | Studies |
|---|---|
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Hangzhou Zede Pharma-Tech Co., Ltd. (4)
Studies
Open first, then newest update. How each study uses CN128 is read from its arms, and is right about nine times in ten.
Testing it · 4
- Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded PatientsCompletedPhase 2Hangzhou Zede Pharma-Tech Co., Ltd.NCT05355766Written as CN128 Tablets
- Long-term Clinical Study of CN128 in Thalassemia PatientsCompletedPhase 2Hangzhou Zede Pharma-Tech Co., Ltd.NCT04614779Written as CN128 Tablets
- Short-term Clinical Study of CN128 in Thalassemia PatientsCompletedPhase 1Hangzhou Zede Pharma-Tech Co., Ltd.NCT03935633Written as CN128 Tablets
- Clinical Study of CN128 in Thalassemia PatientsCompletedPhase 1Hangzhou Zede Pharma-Tech Co., Ltd.NCT03673085Written as CN128